Clinical Trial Update: Efficacy and Safety of Accell Evo3 Demineralized Bone Matrix (DBM) in Instrumented Posterolateral Lumbar Spine Fusion [NA]

View source ↗

Summary

Clinical trial evaluating the efficacy and safety of Accell Evo3 Demineralized Bone Matrix in instrumented posterolateral lumbar spine fusion has completed, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease of the Spine
• Lumbar Spinal Stenosis
• Spondylosis

Drugs mentioned

• Accell Evo3 Demineralized Bone Matrix (demineralized bone matrix)

Snippet

Sponsor: SeaSpine, Inc. | Conditions: Stenosis, Spondylosis | NA | Status: COMPLETED | Results posted: 2018-02-28